Rituximab in the treatment of Graves’ disease and endocrine ophthalmopathy. Opportunities and limitations
Rituximab is a chimeric (mouse and human) monoclonal antibody against B-lymphocytes (CD20). This drug is widely used in rheumatology in the treatment of rheumatoid arthritis, Sjogren’s syndrome, some systemic connective tissue diseases and vasculitis, as well as in hematology in lymphoproliferative...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
IMA PRESS LLC
2023-10-01
|
| Edice: | Научно-практическая ревматология |
| Témata: | |
| On-line přístup: | https://rsp.mediar-press.net/rsp/article/view/3410 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|